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Several factors play a role in obesity (i.e., behavior, environment, and genetics) and
epigenetic regulation of gene expression has emerged as a potential contributor in
the susceptibility and development of obesity. To investigate the individual sensitivity
to weight gain/resistance, we here studied gene transcription regulation of several
hypothalamic neuropeptides involved in the control of energy balance in rats developing
obesity (diet-induced obesity, DIO) or not (diet resistant, DR), when fed with a high
fat diet. Rats have been followed up to 21 weeks of high fat diet exposure. After 5
weeks high fat diet exposure, the obese phenotype was developed and we observed
a selective down-regulation of the orexigenic neuropeptide Y (NPY) and peroxisome
proliferator-activated receptor gamma (PPAR-γ) genes. No changes were observed in
the expression of the agouti-related protein (AgRP), as well as for all the anorexigenic
genes under study. After long-term high fat diet exposure (21 weeks), NPY and PPAR-γ,
as well as most of the genes under study, resulted not be different between DIO and DR,
whereas a lower expression of the anorexigenic pro-opio-melanocortin (POMC) genewas
observed in DIO rats when compared to DR rats. Moreover we observed that changes in
NPY and POMCmRNA were inversely correlated with gene promoters DNA methylation.
Our findings suggest that selective alterations in hypothalamic peptide genes regulation
could contribute to the development of overweight in rats and that environmental factor,
as in this animal model, might be partially responsible of these changes via epigenetic
mechanism.
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Introduction
Obesity is the consequence of an imbalance between energy
intake and expenditure. The prevalence of obesity all over the
world suggests that there is a fundamental weakness in the
regulation of appetite and energy homeostasis. Feeding behavior
and body weight are controlled through complex interactions
between the central nervous system (CNS) and peripheral organs.
Short- and long-term hormonal and neural signals regulate
food intake and energy expenditure through the modulation
of orexigenic and anorexigenic neuropeptides expression in the
hypothalamus and in other brain regions involved in the control
of the homeostasis (Woods et al., 1998; Schwartz et al., 2000).
Critical elements of this control system are hormones secreted
in proportion to body adiposity, including leptin and insulin,
and the CNS targets upon which they act (Hewson et al.,
2002).
In recent years, several evidences have been accumulated on
the effects of a large number of hypothalamic neuropeptides
on food intake, including neuropeptide Y (NPY), galanin,
cocaine and amphetamine regulated transcript (CART), melanin
concentrating hormone (MCH), agouti-related protein (AgRP),
and pro-opio-melanocortin (POMC)-derived peptides, such as
α-melanocyte-stimulating hormone (α-MSH) and β-endorphin
(Woods et al., 1998). The activation of NPY/AGRP neurons
has an orexigenic effect, promoting food intake, whereas the
activation of POMC/CART neurons evoke an anorexigenic effect
(Barsh and Schwartz, 2002).
These two sets of neurons receive inputs from several
endocrine hormones such as leptin, secreted from the adipose
tissue, which exerts its effects via the leptin receptor (lepR). In
particular leptin regulates body weight homeostasis and energy
balance (Friedman and Halaas, 1998; Meister, 2000) by acting
at hypothalamic level inhibiting the NPY/AGRP pathway and
stimulating POMC/CART neurons (Bell et al., 2005).
Recently a crucial role has been also proposed for the
peroxisome proliferator-activated receptor gamma (PPAR-γ),
already known to be relevant for energy homeostasis in POMC
hypothalamic neurons (Long et al., 2014). In particular Long and
his group demonstrated that PPAR-γ mediates several cellular,
biological, and functional adaptations of POMC neurons in mice
exposed to a fat enrich diet (Long et al., 2014).
Diet-induced obesity in rats provides a useful animal model
sharing several common features with human obesity (Levin
and Dunn-Meynell, 2000), including a polygenic mode in
inheritance. Many studies have shown in different strains of
rodents that, after exposure to a high fat diet, some animals
become obese (DIO) while others remain lean (DR) (Surwit et al.,
1997; Bergen et al., 1999; Levin and Dunn-Meynell, 2000; Tian
et al., 2004). These weight-gain patterns appear to be inherited
as polygenic (Levin et al., 1997, 2003; Levin and Govek, 1998).
Before the onset of obesity, outbred DIO-prone rats show a
number of abnormalities of nervous system function, which
might predispose them to develop obesity when offered a 31%
fat, high-energy diet (Levin and Routh, 1996). The molecular
mechanisms of this different response to dietary factors are still
largely unknown.
Obesity is a classic example of interaction between
environment (e.g., diet) and heredity and among the several
mechanisms that could lead to interindividual differences to
develop obesity, the epigenetic regulation of gene expression has
emerged in the last years as a potentially important contributor
(Lavebratt et al., 2012). Epigenetic processes consist of mitotically
heritable, but reversible, changes in gene accessibility that occur
without a change in the genomic DNA sequence (Russo et al.,
1996). The main epigenetic mechanisms essentially include DNA
methylation and histone modifications (Feng et al., 2007). DNA
methylation, in particular, consists of the transfer of a methyl
group to position 5 of the cytosine pyrimidine ring of a cytosine
guanine dinucleotide (CpG), which ultimately blocks the binding
of transcription factors causing chromatin compaction and gene
silencing. Reports have identified epigenetic modifications in the
CNS in response to altered diet, particularly in the prenatal or
early postnatal time period (Vucetic et al., 2010a,b). However,
few studies investigated the postnatal period and, in this
frame, the search for gene promoters susceptible to epigenetic
regulation, with a role in the development of obesity, could be of
great interest.
On the basis of above considerations, in the present study we
investigated the individual sensitivity to weight gain/resistance,
following a hypercaloric diet. In particular we evaluated the
hypothalamic gene expression and possible epigenetic regulation
of selected neuropeptides involved in the control of energy
balance in rats that develop obesity (diet-induced obesity, DIO),
or do not develop obesity (diet resistant, DR), when fed with a
high fat diet. Namely, we studied the transcriptional regulation
of the peptides NPY, AGRP, POMC, CART as well as of the two
receptors PPAR-γ and lepR.
Methods
Subjects and Diet Composition
Male Sprague Dawley rats (Charles River; total n = 56; 175–
200 g at the beginning of the experiments) were used. Rats were
housed in individual cages under 12 h:12 h light/dark cycle (lights
on at 9:00 a.m.) with access to food and water ad libitum for
2 weeks before the experiments. They were kept in a room at
constant temperature (20–22◦C) and humidity (45–55%). All
experiments were performed in accordance with the European
directive 86/609/EEC governing animal welfare and protection,
which is acknowledged by Italian Legislative Decree n. 116,
January 27, 1992. Rats were randomly divided into two groups
with comparable mean body weight (no significant difference).
The first group (n = 6) was the control group and was fed with
standard laboratory chow ad libitum (4RF18, Mucedola, Settimo
Milanese, Italy; 2.6 kcal/g); the second group (n = 50), was fed
with high energy diet (45% fat, 35% Carbohydrate, 20% Protein)
ad libitum (D12451, Research Diets, Inc., New Brunswick, NJ;
5.24 kcal/g).
After 5 weeks, rats fed with high fat diet showed a different
sensitivity to the diet so that they were divided in two different
group: the rats which increased significantly their body weight in
comparison to the control group were designated as diet induced
obesity (DIO) rats (n = 39), while the rats that gain the same
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body weight of control group were designated as diet resistance
(DR) rats (n = 11). At the end of the 5 weeks, 7 DIO rats and 5
DRwere sacrificed by decapitation. Brains were quickly removed,
placed in an ice-cold matrix and hypothalamus was collected.
The remaining rats, 32 DIO and 6 DR rats were maintained on
their respective diets for 21 weeks. At the end of the 21st week,
6 DIO and 6 DR were sacrificed by decapitation and brains were
collected to be analyzed. Body weight and food intake between
sacrificed rats (6) and remained rats (26) were not significantly
different (P > 0.05).
Body weight and food intake were daily measured.
Real-time qPCR (RT-qPCR)
Total RNA was isolated from the hypothalami, according
to the method of Chomczynski and Sacchi (2006). RT-PCR
reactions were performed using the RevertAid H Minus First
Strand cDNA Synthesis Kit (Thermo Scientific, Waltham, MA,
USA). The relative abundance of each mRNA species was
assessed by quantitative real-time RTPCR (qRTPCR), using
SensiFAST SYBR No-ROX Kit (Bioline) on a DNA Engine
Opticon 2 Continuous Fluorescence Detection System (MJ
Research, Waltham, MA, USA). All data were normalized to the
endogenous reference genes β-actin and GAPDH. The primers
used for PCR amplification are provided in Table 1S.
One µl of the first strand cDNA product was used for
amplification in triplicate in 20µl reaction solution, containing
10µl of SensiFAST SYBR No-ROX Kit and 10 pmol of each
primer. The following PCR program was used: 95◦C for 10min,
followed by 50 amplification cycles of 95◦C for 10 s, 57◦C
for 30 s, and 72 for 30 s. Relative expression of different gene
transcripts was calculated by the Delta-Delta Ct (DDCt) method
and converted to relative expression ratio (2−DDCt) for statistical
analysis (Livak and Schmittgen, 2001). All data were normalized
to the endogenous reference genes glyceraldehyde-3-phosphate
dehydrogenase and beta-actin expression, properly validated to
confirm that their expression was unaffected by our experimental
condition.
Analysis of DNA Methylation
Methylation status of gene promoter regions was determined
using pyrosequencing of bisulfite converted DNA. Details of
pyrosequencing assays used including primer sequences and
QIAGEN (Hilden, Germany) assay names are provided in
Table 1S. After DNA extraction, 0.5µg of DNA from each
sample was treated with bisulfite, using a DNA methylation
kit (Zymo Research, Orange, CA, USA). Bisulfite treated DNA
was amplified by PyroMark PCR Kit (Qiagen) according to
manufacturer’s protocol. PCR conditions were as follows: 95◦C
for 15min, followed by 45 cycles of 94◦C for 30 s, 56◦C for 30 s,
72◦C for 30 s, and finally, 72◦C for 10min. PCR products were
verified by agarose electrophoresis. Pyrosequencing methylation
analysis was conducted using the PyroMark Q24 (Qiagen). The
level of methylation was analyzed using PyroMark Q24 Software
(Qiagen), which calculates the methylation percentage [mC/(mC
+ C)] for each CpG site, allowing quantitative comparisons (mC
is methylated cytosine, C is unmethylated cytosine).
Statistical Analysis
In behavioral experiments, data were analyzed by Two-Way
ANOVA with the animal group as the between-subject variable
and time as the within-subject variable, followed by post-hoc
comparison carried out by the Bonferroni test.
In molecular biology studies, data were analyzed by One-
Way ANOVA or Two-Way ANOVA with the animal group as
the between-subject variable and CpG sites as the within-subject
variable, followed by post-hoc comparison carried out by the
Bonferroni test. Statistical significance was set at P < 0.05.
Results
High Fat Diet Effects on Body Weight and Food
Intake
At the beginning of the study, body weight of rats in the high fat
diet group (265.4 ± 2.4 g) did not differ significantly from that
of the rats in the control group (267 ± 6.5 g) [F(1, 54) = 0.05;
P > 0.05]. At the end of the fifth week, Two-Way ANOVA
showed a significant difference in body weight among the groups
(Groups: [F(2, 53) = 5.81; P < 0.01]; Time [F(4, 212) = 566.63;
P < 0.01]; Interaction: [F(8, 212) = 5.94; P < 0.01]). At the
fifth week time point, post-hoc test showed that the average body
weight of DIO rats (457.3± 4.0 g) began to be significantly higher
compared to DR rats (410, 1 ± 7.4 g) (P < 0.05) and control
group (429.8± 6.8 g) (P < 0.05).
At the end of the 21st week, Two-Way ANOVA showed a
significant difference in body weight among the groups (Groups:
[F(2, 41) = 48.30; P < 0.01]; Time [F(15, 615) = 327.86; P <
0.01]; Interaction: [F(30, 615) = 12.93; P < 0.01]). At the last
time point (21st week) of free access to high fat diet, post-hoc
test showed that body weight of DIO rats was significantly higher
(716.4 ± 8.4 g) in comparison to body weight of rats fed with
standard diet (591.0 ± 2.2 g) (P < 0.05). Body weight of DR
animals (593.5 ± 14.4 g) fed with high fat diet was comparable
to body weight of rats fed with standard diet (P > 0.05). These
rats were resistant to develop obesity (Figure 1A).
Overall ANOVA showed a significant different in energy
intake (kcal) among the three groups in the first 5 weeks (Groups:
[F(2, 53) = 20.39; P < 0.01]; Time [F(4, 212) = 14.85; P < 0.01];
Interaction: [F(8, 212) = 3.74; P < 0.01]) and from week 6 to
week 21 (Groups: [F(2, 41) = 18.52; P < 0.01]; Time [F(15, 615) =
13.85.; P < 0.01]; Interaction: [F(30, 615) = 2.18; P < 0.01]).
Significant differences at each time point are expressed in the
Figure 1B.
Regulation of Genes Transcription
After 5 and 21 continuous weeks of free access to high fat diet,
we detected the gene expression of NPY, AGRP, POMC, CART
peptide precursors, as well as of the two receptors PPAR-γ and
lepR (Figures 2, 3).
As reported in Figure 2, there was a significant decrease of
NPY [F(1, 9) = 9.45; P < 0.05] and PPAR-γ [F(1, 9) = 8.78;
P < 0.05] mRNA levels in the hypothalamus of DR rats
respect to DIO rats sacrificed after 5 weeks of high fat diet
exposure (Figures 2A,C). No changes were detected in AGRP
gene expression levels [F(1, 9) = 0.52; P > 0.05] (Figure 2B).
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FIGURE 1 | (A) Body weight measured weekly for chow, DIO and DR rats.
#P < 0.05, ##P < 0.01, ###P < 0.001 DIO vs. chow; ***P < 0.001 DIO
vs. DR. (B) Cumulative food intake measured weekly for chow, DIO and DR
rats. #P < 0.05, ##P < 0.01, ###P < 0.001 chow vs. DIO; $P < 0.05,
$$P < 0.01, $$$P < 0.001 chow vs. DR; *P < 0.05 DR vs. DIO.
In Figure 3, we reported the gene expression analysis of POMC,
CART, and lepR that was not different between DIO and DR rats
at 5 weeks (Figure 3A). After 21 weeks of free access to high fat
food, a significant increase was observed only in POMC gene
expression in DR rats [F(1, 9) = 5.54; P < 0.05] respect to DIO
group (Figure 3B).
DNA Methylation at Gene Promoters
In order to evaluate the potential relationship between the
observed significant alterations in genes expression and
epigenetic regulation, we analyzed the DNA methylation at gene
promoters of NPY, PPAR-γ (5 weeks) and POMC (21 weeks).
Methylation of the combined CpG sites examined in the
promoter region of NPY at 5 week (from −3 to −36 upstream
the transcription start site) did not show significant difference
in the % of DNA methylation in DR rats respect to DIO groups
[F(1, 8) = 0.98; P > 0.05] (Figure 4A). The overall ANOVA of 5
CpG sites present on NPY promoter region showed significant
changes between the experimental groups (Groups: [F(1, 8) =
9.91; P < 0.05]; CpG [F(4, 32) = 14.41; P < 0.01]; Interaction:
[F(4, 32) = 3.15; P < 0.05]). Post-hoc analysis revealed a selective
significant increase in DNA methylation for the 5th CpG site in
the DR rats (as shown in Figure 4B).
FIGURE 2 | Gene expression analysis of (A) NPY, (B) AgRP, and (C)
PPAR-γ after 5 and 21 weeks of high fat diet exposure. Gene expression
was normalized to glyceraldehyde-3-phosphate dehydrogenase and β-actin.
Values are expressed as mean ± SEM of 6–8 rats. *P < 0.05, **P < 0.01
vs. DIO.
Methylation of the combined CpG sites examined in
the promoter region of PPAR-γ at 5 week (from −387
to −434) did not show significant difference in the % of DNA
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FIGURE 3 | RT-qPCR analysis of (A) CART, (B) POMC, and (C) LepR
gene expression after 5 and 21 weeks of high fat diet exposure. Gene
expression was normalized to glyceraldehyde-3-phosphate dehydrogenase
and β-actin. Values are expressed as mean ± SEM of 6–8 rats. *P < 0.05
vs. DIO.
methylation in DR rats respect to DIO groups [F(1, 8) =
0.001; P > 0.05] (Figure 4C). The overall ANOVA of 6
CpG sites present on PPAR-γ promoter region did not show
significant changes between the experimental groups (Groups:
[F(1, 10) = 0.001; P > 0.05]; CpG [F(5, 50) = 11.44;
P < 0.05]; Interaction: [F(5, 50) = 0.32; P > 0.05])
(Figure 4D).
Methylation of the combined CpG sites examined in the
promoter region of POMC at 21 week (from−1 to−59) showed
significant reduction in the % of DNA methylation in DR rats
respect to DIO groups [F(1, 6) = 6.85; P < 0.05] (Figure 4E).
The overall ANOVA of 8 CpG sites present on POMC promoter
region showed significant changes between the experimental
groups (Groups: [F(1, 6) = 6.85; P < 0.05]; CpG [F(7, 42) =
142.1; P < 0.01]; Interaction: [F(7, 42) = 2.32; P < 0.05])
(Figure 4E). Post-hoc analysis revealed a selective significant
decrease in DNA methylation levels at four specific CpG sites,
respectively in the 1st and 6th, and in the 2nd and 7th CpG sites
(Figure 4F).
Discussion
Obesity results from the complex interaction of genetic
components and environment, which facilitates the development
of obese phenotype (Perusse and Bouchard, 2000). High-fat diet
is among the most important environment factors leading to
obesity and models of DIO are commonly used to study the
disease. Our findings confirmed that the outbred Sprague Dawley
rats exhibited different phenotype after exposed to high-fat diet
and the body weight resulted significantly increased in DIO rats
when compared to DR rats starting after 5 weeks of exposure and
up to 21 weeks. Previous studies indicated that increased energy
intake should be the primarily responsible for body weight gain in
DIO rats on high-fat diet ad libitum, whereas DR rats exposed to
high-fat diet compensated for the increased energy density of the
high-fat diet by eating significantly less (Levin et al., 1989; Ricci
and Levin, 2003). In our study, food intake of DR rats showed
a clear trend to be lower than food intake of DIO rats but the
difference was statistically significant only at one time point (4th
week).
To evaluate the possible mechanisms responsible of obesity
development, we investigated the expression of selected
hypothalamic neuropeptides and receptors known to be involved
in in the control of body weight.
In the complex system of hypothalamic signals regulating
energy homeostasis, we evaluated if there is also an
interconnection in gene regulation between NPY/AgRP
and POMC/CART, where the NPY/AgRP neurons might
down-regulate POMC neurons (Cowley et al., 2001).
Among the different genes under investigation, we observed,
after 5 weeks high fat diet exposure, a selective down-regulation
of NPY and PPAR-γ genes expression in DR when compared
to DIO rats, and no changes for AgRP as well as for all the
anorexigenic genes mRNA levels.
NPY is one the most potent orexigenic peptides in the
brain and, consistently with our findings, previously it has
been observed that high-fat-sucrose diet in prenatally stressed
female adult rats induces an increase in NPY mRNA levels
(Paternain et al., 2012). Moreover NPY mRNA levels were
found to be higher also in DIO group when compared
to DR group in the hypothalamus (Wang et al., 2007).
Interestingly, NPY knockdown in the hypothalamus increases
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FIGURE 4 | Percentage of DNA methylation assessed with
bisulfite pyrosequencing in the hypothalamus of rats for: NPY
gene promoter at all CpGs combined (A) and at each single
site (B) (**P < 0.01 vs. DIO) after 5 weeks of high fat diet
exposure; PPAR-γ gene promoter at all CpGs combined (C)
and at each single site (D) after 5 weeks of high fat diet
exposure; POMC gene promoter at all CpGs combined (E) and
at each single site (F) (*P < 0.05, **P < 0.01 vs. DIO) after 21
weeks of high fat diet exposure. Values are expressed as
mean ± SEM of 6–8 rats.
energy expenditure (Chao et al., 2011) and its overexpression
within the paraventricular nucleus induced obesity via increased
food intake (Tiesjema et al., 2009).
Instead, we did not observe alterations in AgRP gene
expression which it is synthesized exclusively in the arcuate
nucleus (Morton and Schwartz, 2001; Valassi et al., 2008), where
it co-localizes with NPY.
In this work we studied the entire hypothalamic region and
NPY is also expressed in other hypothalamic areas apart from the
arcuate and this could be the reason why we observed changes
only in this gene.
Consistently with NPY gene expression changes, we report a
reduction in PPAR-γ mRNA levels in DR. Again, this finding is
in agreement with a previous study showing that hypothalamic
PPAR-γ gene expression is higher in DIO mice when compared
with lean controls (Diano et al., 2011). The deletion of PPAR-γ
gene in neurons (Lu et al., 2011) or its chemical inhibition in the
hypothalamus, protects against the development of DIO (Ryan
et al., 2011). Moreover, during high-fat diet feeding, food intake
was reduced and energy expenditure increased in PPAR-γ KO
mice resulting in reduced weight gain (Lu et al., 2011).
Interestingly, we have observed that these alterations are time-
dependent since these were not evident anymore at the latest
time-point under study (21 weeks), but just when the obese
phenotype starts to develop. It could be hypothesized that NPY
and PPAR-γ orexigenic role is not any longer of relevance
once the obese phenotype is established. This observation might
be even more relevant when taking into account the possible
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epigenetic regulation of these genes expression. In fact, even if
there is globally a hypomethylation in all animals consistent with
the observations of others (Plagemann et al., 2009; Mahmood
et al., 2013), we found an even lower DNA methylation at NPY
gene promoter in DR animals. Changes in DNA methylation of
specific CpG sites at NPY gene promoter in the hypothalamus
of rats on a high-carbohydrate milk formula have also been
recently reported (Mahmood et al., 2013). Instead, no changes
in NPY gene expression, as well as promoter DNA methylation,
was observed in a rat model for the study of the effects
of overnourishment during the suckling period (Plagemann
et al., 2009). In addition, others reported altered expression of
hypothalamic neuropeptide genes such as Npy, Agrp, and Pomc
but non-correlated with DNA methylation changes (Shin et al.,
2012).
One important point is that changes in gene expression
regulation are selective, since no alterations have been observed
for the other genes under study, and selectively limited at the
5 weeks time-point. We might thus hypothesize that orexigenic
genes (NPY and PPAR-γ in this study), if activated in early
events, would be responsible of the maintenance of the obese
phenotype even if their regulation is not needed anymore
when this phenotype is already well-established. Moreover,
the epigenetic regulation of NPY might suggest that the
overexpression is reversible via environmental stimuli and thus
obesity development could be avoided if early counteracted.
After 21 weeks exposure to high fat diet, we observed that
the expression of most of the genes under study resulted not be
different between DIO and DR, beside the lower mRNA levels of
the anorexigenic POMC gene in DIO rats when compared to DR.
A reduction in POMC gene expression was also observed in the
hypothalamus of female rats on high-carbohydrate milk formula
(Srinivasan et al., 2008; Mahmood et al., 2013). It is known that
α-MSH, derived from POMC, inhibits food intake and enhances
energy expenditure mainly through activation of melanocortin
receptors in the hypothalamus and that it is effective especially
against adult-onset obesity (Hansen et al., 2001; Hwa et al.,
2001; Zhang et al., 2004). This is of relevance in the frame
of our findings of POMC gene regulation at the longest time-
point to demonstrate its importance on long-term body weight
maintenance.
Moreover, we here show that POMC expression at week
21 is strongly influenced by promoter methylation, as already
reported by others (Newell-Price et al., 2001). In fact, we
observed, in DR group when compared to DIO rats, significant
reductions of DNA methylation at four of the eight CpG
sites investigated in the proximal promoter region of POMC,
thus negatively correlated with the observed increase in gene
expression. This is in agreement with other studies, using
different animal models. Namely, in an animal model of
overnutrition during the suckling period, a CpG dinucleotide
located in the GRE-binding site, a negative regulator of Pomc
expression, resulted hypomethylated (Plagemann et al., 2009). In
another rodent model, feeding of a low-protein diet to pregnant
rats induced a mismatched correlation between POMC gene
expression and CpG methylation status in the offspring (Coupe
et al., 2010). However, others also reported that in high-fat
diet-fed obese mice, altered expression of POMC and LepR in
the hypothalamus was not to correlated with changes in DNA
methylation at gene promoters (Fan et al., 2011).
Conclusions
We here provide evidence of selective and time dependent
transcriptional regulation of target genes in DIO rat model when
compared to DR. These alterations in peptide genes regulation
would contribute to develop overweight in rats possibly for the
hedonic impact of palatable food in DIO rats when compared to
DR. It is important to underline that observed changes appear
to be relevant at the earliest time-point under study. This allows
to hypothesize that it is crucial to identify alterations in gene
transcription at the very beginning of obesity development,
if one aims at predicting disease trajectories and choosing
the most effective therapy. Moreover, the reversible nature of
epigenetic modifications makes them attractive targets for a
possible epigenetic therapy of obesity. In addition, understanding
how environmental factors, as in this animalmodel, might induce
obesity would be of help to disclosure changes occurring in
central circuits. Such an epigenetic regulation appears to hold
better promises than alterations detected in genetic models of
obesity (Kalra et al., 1999), which most often do not reproduce
the changes occurring in natural populations affected by the
disease.
Further studies are needed to dissect gene expression
regulation and DNAmethylation patterns of other possible genes
involved in obesity development, possibly looking at distinct
target tissues, not only within the CNS, but also at the periphery
(adipose tissue, liver etc.).
Acknowledgments
The work was supported by the ItalianMinistry of University and
Research under grants FIRB-RBFR12DELS to CC and CD, and
PRIN-2012JTX3KL to CC. The authors declare no competing
financial interests.
Supplementary Material
The Supplementary Material for this article can be found
online at: http://journal.frontiersin.org/article/10.3389/fnins.
2015.00187/abstract
Frontiers in Neuroscience | www.frontiersin.org 7 June 2015 | Volume 9 | Article 187
Cifani et al. Hypothalamic neuropeptides expression in obesity
References
Barsh, G. S., and Schwartz, M. W. (2002). Genetic approaches to studying
energy balance: perception and integration. Nat. Rev. Genet. 3, 589–600. doi:
10.1038/nrg862
Bell, C. G., Walley, A. J., and Froguel, P. (2005). The genetics of human obesity.
Nat. Rev. Genet. 6, 221–234. doi: 10.1038/nrg1556
Bergen, H. T., Mizuno, T., Taylor, J., and Mobbs, C. V. (1999). Resistance to
diet-induced obesity is associated with increased proopiomelanocortin mRNA
and decreased neuropeptide Y mRNA in the hypothalamus. Brain Res. 851,
198–203. doi: 10.1016/S0006-8993(99)02186-1
Chao, P. T., Yang, L., Aja, S., Moran, T. H., and Bi, S. (2011). Knockdown of NPY
expression in the dorsomedial hypothalamus promotes development of brown
adipocytes and prevents diet-induced obesity. Cell Metab. 13, 573–583. doi:
10.1016/j.cmet.2011.02.019
Chomczynski, P., and Sacchi, N. (2006). The single-step method of RNA
isolation by acid guanidinium thiocyanate-phenol-chloroform extraction:
twenty-something years on.Nat. Protoc. 1, 581–585. doi: 10.1038/nprot.2006.83
Coupe, B., Amarger, V., Grit, I., Benani, A., and Parnet, P. (2010). Nutritional
programming affects hypothalamic organization and early response to leptin.
Endocrinology 151, 702–713. doi: 10.1210/en.2009-0893
Cowley, M. A., Smart, J. L., Rubinstein, M., Cerdan, M. G., Diano, S., Horvath, T.
L., et al. (2001). Leptin activates anorexigenic POMC neurons through a neural
network in the arcuate nucleus. Nature 411, 480–484. doi: 10.1038/35078085
Diano, S., Liu, Z. W., Jeong, J. K., Dietrich, M. O., Ruan, H. B., Kim, E., et al.
(2011). Peroxisome proliferation-associated control of reactive oxygen species
sets melanocortin tone and feeding in diet-induced obesity. Nat. Med. 17,
1121–1127. doi: 10.1038/nm.2421
Fan, C., Liu, X., Shen, W., Deckelbaum, R. J., and Qi, K. (2011). The Regulation of
leptin, leptin receptor and pro-opiomelanocortin expression by N-3 PUFAs in
diet-induced obese mice is not related to the methylation of their promoters.
Nutr. Metab. 8:31. doi: 10.1186/1743-7075-8-31
Feng, J., Fouse, S., and Fan, G. (2007). Epigenetic regulation of neural
gene expression and neuronal function. Pediatr. Res. 61, 58R-63R. doi:
10.1203/pdr.0b013e3180457635
Friedman, J. M., and Halaas, J. L. (1998). Leptin and the regulation of body weight
in mammals. Nature 395, 763–770. doi: 10.1038/27376
Hansen, M. J., Ball, M. J., and Morris, M. J. (2001). Enhanced inhibitory feeding
response to alpha-melanocyte stimulating hormone in the diet-induced obese
rat. Brain Res. 892, 130–137. doi: 10.1016/S0006-8993(00)03246-7
Hewson, A. K., Tung, L. Y., Connell, D. W., Tookman, L., and Dickson, S.
L. (2002). The rat arcuate nucleus integrates peripheral signals provided
by leptin, insulin, and a ghrelin mimetic. Diabetes 51, 3412–3419. doi:
10.2337/diabetes.51.12.3412
Hwa, J. J., Ghibaudi, L., Gao, J., and Parker, E. M. (2001). Central melanocortin
systemmodulates energy intake and expenditure of obese and lean Zucker rats.
Am. J. Physiol. Regul. Integr. Comp. Physiol. 281, R444–R451.
Kalra, S. P., Dube, M. G., Pu, S., Xu, B., Horvath, T. L., and Kalra, P. S. (1999).
Interacting appetite-regulating pathways in the hypothalamic regulation of
body weight. Endocr. Rev. 20, 68–100. doi: 10.1210/edrv.20.1.0357
Lavebratt, C., Almgren, M., and Ekstrom, T. J. (2012). Epigenetic regulation in
obesity. Int. J. Obes. 36, 757–765. doi: 10.1038/ijo.2011.178
Levin, B. E., and Dunn-Meynell, A. A. (2000). Defense of body weight against
chronic caloric restriction in obesity-prone and -resistant rats. Am. J. Physiol.
Regul. Integr. Comp. Physiol. 278, R231–R237.
Levin, B. E., Dunn-Meynell, A. A., Balkan, B., and Keesey, R. E. (1997). Selective
breeding for diet-induced obesity and resistance in Sprague-Dawley rats. Am.
J. Physiol. 273, R725–R730.
Levin, B. E., Dunn-Meynell, A. A., McMinn, J. E., Alperovich, M., Cunningham-
Bussel, A., and Chua, S. C. Jr. (2003). A new obesity-prone, glucose-
intolerant rat strain (F.DIO). Am. J. Physiol. Regul. Integr. Comp. Physiol. 285,
R1184–R1191. doi: 10.1152/ajpregu.00267.2003
Levin, B. E., and Govek, E. (1998). Gestational obesity accentuates obesity in
obesity-prone progeny. Am. J. Physiol. 275, R1374–R1379.
Levin, B. E., Hogan, S., and Sullivan, A. C. (1989). Initiation and perpetuation of
obesity and obesity resistance in rats. Am. J. Physiol. 256, R766–R771.
Levin, B. E., and Routh, V. H. (1996). Role of the brain in energy balance and
obesity. Am. J. Physiol. 271, R491–R500.
Livak, K. J., and Schmittgen, T. D. (2001). Analysis of relative gene expression
data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.
Methods 25, 402–408. doi: 10.1006/meth.2001.1262
Long, L., Toda, C., Jeong, J. K., Horvath, T. L., and Diano, S. (2014). PPARgamma
ablation sensitizes proopiomelanocortin neurons to leptin during high-fat
feeding. J. Clin. Invest. 124, 4017–4027. doi: 10.1172/JCI76220
Lu, M., Sarruf, D. A., Talukdar, S., Sharma, S., Li, P., Bandyopadhyay, G.,
et al. (2011). Brain PPAR-gamma promotes obesity and is required for the
insulin-sensitizing effect of thiazolidinediones. Nat. Med. 17, 618–622. doi:
10.1038/nm.2332
Mahmood, S., Smiraglia, D. J., Srinivasan, M., and Patel, M. S. (2013).
Epigenetic changes in hypothalamic appetite regulatory genes may underlie the
developmental programming for obesity in rat neonates subjected to a high-
carbohydrate dietary modification. J. Dev. Orig. Health Dis. 4, 479–490. doi:
10.1017/S2040174413000238
Meister, B. (2000). Control of food intake via leptin receptors in the hypothalamus.
Vitam. Horm. 59, 265–304. doi: 10.1016/S0083-6729(00)59010-4
Morton, G. J., and Schwartz, M. W. (2001). The NPY/AgRP neuron and energy
homeostasis. Int. J. Obes. Relat. Metab. Disord. 25 Suppl. 5, S56–S62. doi:
10.1038/sj.ijo.0801915
Newell-Price, J., King, P., and Clark, A. J. L. (2001). The CpG island promoter of
the human proopiomelanocortin gene is methylated in nonexpressing normal
tissue and tumors and represses expression.Mol. Endocrinol. 15, 338–348. doi:
10.1210/mend.15.2.0599
Paternain, L., Batlle, M. A., De La Garza, A. L., Milagro, F. I., Martinez, J.
A., and Campion, J. (2012). Transcriptomic and epigenetic changes in the
hypothalamus are involved in an increased susceptibility to a high-fat-sucrose
diet in prenatally stressed female rats. Neuroendocrinology 96, 249–260. doi:
10.1159/000341684
Perusse, L., and Bouchard, C. (2000). Gene-diet interactions in obesity.Am. J. Clin.
Nutr. 72, 1285S-1290S.
Plagemann, A., Harder, T., Brunn, M., Harder, A., Roepke, K., Wittrock-
Staar, M., et al. (2009). Hypothalamic proopiomelanocortin promoter
methylation becomes altered by early overfeeding: an epigenetic model
of obesity and the metabolic syndrome. J. Physiol. 587, 4963–4976. doi:
10.1113/jphysiol.2009.176156
Ricci, M. R., and Levin, B. E. (2003). Ontogeny of diet-induced obesity in selectively
bred Sprague-Dawley rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 285,
R610–R618. doi: 10.1152/ajpregu.00235.2003
Russo, V. E. A., Martienssen, R. A., and Riggs, A. D. (1996). Epigenetic Mechanisms
of Gene Regulation. Plainview, NY: Cold Spring Harbor Laboratory Press.
Ryan, K. K., Li, B., Grayson, B. E., Matter, E. K., Woods, S. C., and Seeley, R. J.
(2011). A role for central nervous system PPAR-gamma in the regulation of
energy balance. Nat. Med. 17, 623–626. doi: 10.1038/nm.2349
Schwartz, M. W., Woods, S. C., Porte, D. Jr., Seeley, R. J., and Baskin, D. G.
(2000). Central nervous system control of food intake. Nature 404, 661–671.
doi: 10.1038/35007534
Shin, B. C., Dai, Y., Thamotharan, M., Gibson, L. C., and Devaskar, S. U. (2012).
Pre- and postnatal calorie restriction perturbs early hypothalamic neuropeptide
and energy balance. J. Neurosci. Res. 90, 1169–1182. doi: 10.1002/jnr.23013
Srinivasan, M., Mitrani, P., Sadhanandan, G., Dodds, C., Shbeir-Eldika, S.,
Thamotharan, S., et al. (2008). A high-carbohydrate diet in the immediate
postnatal life of rats induces adaptations predisposing to adult-onset obesity.
J. Endocrinol. 197, 565–574. doi: 10.1677/JOE-08-0021
Surwit, R. S., Petro, A. E., Parekh, P., and Collins, S. (1997). Low plasma leptin
in response to dietary fat in diabetes- and obesity-prone mice. Diabetes 46,
1516–1520. doi: 10.2337/diab.46.9.1516
Tian, D. R., Li, X. D., Shi, Y. S., Wan, Y., Wang, X. M., Chang, J. K., et al. (2004).
Changes of hypothalamic alpha-MSH and CART peptide expression in diet-
induced obese rats. Peptides 25, 2147–2153. doi: 10.1016/j.peptides.2004.08.009
Tiesjema, B., La Fleur, S. E., Luijendijk, M. C., and Adan, R. A. (2009). Sustained
NPY overexpression in the PVN results in obesity via temporarily increasing
food intake. Obesity (Silver. Spring). 17, 1448–1450. doi: 10.1038/oby.2008.670
Valassi, E., Scacchi, M., and Cavagnini, F. (2008). Neuroendocrine
control of food intake. Nutr. Metab. Cardiovasc. Dis. 18, 158–168. doi:
10.1016/j.numecd.2007.06.004
Vucetic, Z., Kimmel, J., Totoki, K., Hollenbeck, E., and Reyes, T. M. (2010a).
Maternal high-fat diet alters methylation and gene expression of dopamine
Frontiers in Neuroscience | www.frontiersin.org 8 June 2015 | Volume 9 | Article 187
Cifani et al. Hypothalamic neuropeptides expression in obesity
and opioid-related genes. Endocrinology 151, 4756–4764. doi: 10.1210/en.2010-
0505
Vucetic, Z., Totoki, K., Schoch, H., Whitaker, K. W., Hill-Smith, T., Lucki, I., et al.
(2010b). Early life protein restriction alters dopamine circuitry. Neuroscience
168, 359–370. doi: 10.1016/j.neuroscience.2010.04.010
Wang, C., Yang, N., Wu, S., Liu, L., Sun, X., and Nie, S. (2007). Difference of NPY
and its receptor gene expressions between obesity and obesity-resistant rats in
response to high-fat diet. Horm. Metab. Res. 39, 262–267. doi: 10.1055/s-2007-
973073
Woods, S. C., Seeley, R. J., Porte, D. Jr., and Schwartz, M. W. (1998). Signals
that regulate food intake and energy homeostasis. Science 280, 1378–1383. doi:
10.1126/science.280.5368.1378
Zhang, Y., Matheny, M., Tumer, N., and Scarpace, P. J. (2004). Aged-
obese rats exhibit robust responses to a melanocortin agonist and
antagonist despite leptin resistance. Neurobiol. Aging 25, 1349–1360. doi:
10.1016/j.neurobiolaging.2004.02.012
Conflict of Interest Statement: The Editor Luca Steardo declares that, despite
being affiliated to the same institution as author Adele Romano, the review process
was handled objectively and no conflict of interest exists.
Copyright © 2015 Cifani, Micioni Di Bonaventura, Pucci, Giusepponi, Romano,
Di Francesco, Maccarrone and D’Addario. This is an open-access article distributed
under the terms of the Creative Commons Attribution License (CC BY). The use,
distribution or reproduction in other forums is permitted, provided the original
author(s) or licensor are credited and that the original publication in this journal
is cited, in accordance with accepted academic practice. No use, distribution or
reproduction is permitted which does not comply with these terms.
Frontiers in Neuroscience | www.frontiersin.org 9 June 2015 | Volume 9 | Article 187
